跳至主要内容
临床试验/ACTRN12618000167268
ACTRN12618000167268已完成1 期

Contrast-induced nephropathy in chronic kidney disease patients undergoing angiography and treatment with combined induced diuresis and euvolemic fluid resuscitation: a randomised controlled trial.

A/Prof Margaret Arstall0 个研究点目标入组 166 人开始时间: 2018年2月2日最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
166

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Prevention

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Inclusion criteria for this trial include:
  • 1. All adult patients with advanced stage III, IV or V chronic kidney disease (serum creatinine more than 1.6 mg/dl (145 mmol/L) and eGFR of less than 40ml/min/1.73m2, and/or Mehran's risk score of 6-16) undergoing an elective or urgent, diagnostic or therapeutic radiocontrast procedure will be approached for consent.

排除标准

  • Exclusion criteria for this trial include:
  • 1. Patients with contrast allergy
  • 2. Hypersensitivity to furosemide
  • 3. Patient on maintenance haemodialysis or peritoneal dialysis
  • 4. Radiocontrast procedure conducted within 72 hours
  • 5. Contraindication or failure to pass urinary catheter
  • 6. Patients with fluctuating baseline serum creatinine measurements
  • 7. Patients with acute renal failure
  • 8. Patients requiring emergency angiography procedures (e.g. STEMI cases)

研究者

发起方
A/Prof Margaret Arstall

相似试验

Examining the effect of combined induced diuresis... | 临床试验